Evidence map›Paper›PMID 25611319›Full record

Trial reportPloS one2015

Cleavage/alteration of interleukin-8 by matrix metalloproteinase-9 in the female lower genital tract.

M Reza Zariffard, Kathryn Anastos, Audrey L French, Elisaphane Munyazesa, Mardge Cohen, Alan L Landay, Gregory T Spear

Open access · goldAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

M Reza ZariffardDepartment of Immunology/Microbiology, Rush University Medical Center, Chicago, Illinois, United States of America.
Kathryn AnastosDepartments of Medicine and Epidemiology & Population Health, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York, United States of America.
Audrey L FrenchRuth M. Rothstein CORE Center, Stroger Hospital of Cook County, Chicago, Illinois, United States of America.
Elisaphane MunyazesaRwanda Biomedical Center, National Reference Laboratory Division, Laboratory Quality Assurance Direction, Kigali, Rwanda.
Mardge CohenRuth M. Rothstein CORE Center, Stroger Hospital of Cook County, Chicago, Illinois, United States of America.
Alan L LandayDepartment of Immunology/Microbiology, Rush University Medical Center, Chicago, Illinois, United States of America.
Gregory T SpearDepartment of Immunology/Microbiology, Rush University Medical Center, Chicago, Illinois, United States of America.
Rush University Medical Center · USRuth M. Rothstein CORE Center · USAlbert Einstein College of Medicine · USRwanda Biomedical Center · RW

Funding

Women's Interagency HIV Study (WIHS-V)U01AI035004 · NIAID · MONTEFIORE MEDICAL CENTER (BRONX, NY) · PI ANASTOS, KATHRYN M., SHARMA, ANJALI · 1993 to 2018
$65.7M
Women's Interagency HIV Study (WIHS) IV, Chicago ConsortiumU01AI034993 · NIAID · HEKTOEN INSTITUTE FOR MEDICAL RESEARCH · PI COHEN, MARDGE H, FRENCH, AUDREY · 1994 to 2018
$51.0M
DevelopmentalP30AI082151 · NIAID · RUSH UNIVERSITY MEDICAL CENTER · PI LANDAY, ALAN L · 2009 to 2014
$4.6M
NIAID NIH HHS P01 AI08297NIAID NIH HHS P30 AI082151NIAID NIH HHS U01 AI034993NIAID NIH HHS U01 AI035004
6 · The paper itself

Abstract

objectiveInterleukin-8 (IL-8, CXCL8) plays important roles in immune responses at mucosal sites including in the lower genital tract. Since several types of bacteria produce proteases that cleave IL-8 and many types of bacteria can be present in lower genital tract microbiota, we assessed genital fluids for IL-8 cleavage/alteration. STUDY

designGenital fluids collected by lavage from 200 women (23 HIV-seronegative and 177 HIV-seropositive) were tested for IL-8 cleavage/alteration by ELISA.

resultsIL-8 cleaving/altering activity was observed in fluids from both HIV-positive (28%) and HIV-negative women (35%). There was no clear relationship between the activity and the types of bacteria present in the lower genital tract as determined by high-throughput sequencing of the 16S rRNA gene. Protease inhibitors specific for matrix metalloproteinases (MMPs) reduced the activity and a multiplex assay that detects both inactive and active MMPs showed the presence of multiple MMPs, including MMP-1, -3, -7, -8, -9, -10 and -12 in genital secretions from many of the women. The IL-8-cleaving/altering activity significantly correlated with active MMP-9 as well as with cleavage of a substrate that is acted on by several active MMPs.

conclusionsThese studies show that multiple MMPs are present in the genital tract of women and strongly suggest that MMP-9 in genital secretions can cleave IL-8 at this mucosal site. These studies suggest that MMP-mediated cleavage of IL-8 can modulate inflammatory responses in the lower genital tract.

Indexed as

AdultFemaleHIV SeropositivityHumansInterleukin-8Matrix Metalloproteinase 9Middle AgedMucous MembraneProspective StudiesVaginaCXCL8 protein, humanInterleukin-8Matrix Metalloproteinase 9MMP9 protein, human

Identifiers

PMID25611319
PMCPMC4303271
OpenAlexW1969073113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.